Form EFFECT TITAN PHARMACEUTICALS

November 17, 2025 6:16 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 14, 2025
Accession Number: 0001829126-25-008007
Submission Type: POS AM
CIK: 0000910267
Company Name: TITAN PHARMACEUTICALS INC
File Number: 333-252482


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings